NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=129944&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK

NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=129941&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Grocery Outlet Holding Corp.(GO) Shareholders

NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=129940&wire=1 or contact Joseph E.

image for news Investors who lost money on FTAI Aviation Ltd.(FTAI) should contact Levi & Korsinsky about pending Class Action - FTAI

VICI: Why Gamble At The Casino When It Can Pay You 5.7% — Positive

VICI   Seeking Alpha — February 16, 2025

VICI Properties owns prime casino real estate, offering a unique investment opportunity with a strong moat, high margins, and a 5.7% dividend yield. Despite recent stock declines, VICI's valuation metrics are attractive, trading at 11.5x FFO and 8.74x EBITDA, below its peer group averages. VICI's revenue, EBITDA, and net income are growing, positioning it for future profitability and dividend increases as the Fed lowers rates.

image for news VICI: Why Gamble At The Casino When It Can Pay You 5.7%

NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integral Ad Science Holding Corp. (NASDAQ: IAS) between March 2, 2023 and February 27, 2024, inclusive (the “Class Period”), of the important March 31, 2025 lead plaintiff deadline.

image for news ROSEN, NATIONAL TRIAL LAWYERS, Encourages Integral Ad Science Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IAS

NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Light & Wonder, Inc. (NASDAQ: LNW) resulting from allegations that Light & Wonder may have issued materially misleading business information to the investing public.

image for news Light & Wonder, Inc. Investor News: If You Have Suffered Losses in Light & Wonder, Inc. (NASDAQ: LNW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

CACI: A Company I Now Own Despite Quality Downgrade Due To DOGE — Neutral

CACI   Seeking Alpha — February 16, 2025

CACI International Inc. is a resilient, predictable growth company, ideal for long-term investment at the right price. The defense industry is negatively impacted by DOGE. Concerns center around spending cuts and shifting contracts from the higher-margin cost-plus to the lower-margin fixed-price type. CACI's management is optimistic, raising guidance thrice in FY 2025, emphasizing revenue predictability, and highlighting software's importance in recent earnings calls.

image for news CACI: A Company I Now Own Despite Quality Downgrade Due To DOGE

NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=129939&wire=1 or contact Joseph E. Levi, Esq.

image for news Lost Money on AstraZeneca PLC(AZN)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2025.

image for news ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ICON plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICLR

NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive (the “Class Period”), of the important April 7, 2025 lead plaintiff deadline.

image for news ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK

Alibaba: Strategically Bullish As AI Optimism Drives Multiple Higher — Positive

BABA   Seeking Alpha — February 16, 2025

Alibaba's stock jumped nearly 50% in a month, fueled by AI optimism from the DeepSeek news and a potential AI partnership with Apple in China. The company's core retail business is stabilizing, and overall revenue growth has accelerated on a year-over-year basis in 2Q FY2025, driven by strong performance in the cloud segment. While increased spending on AI infrastructure has impacted FCF, down 70% YoY in 2Q, it is expected to drive higher cloud revenue growth, helping to diversify Alibaba's revenue mix.

image for news Alibaba: Strategically Bullish As AI Optimism Drives Multiple Higher

NEW YORK, NY / ACCESS Newswire / February 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FTAI Aviation Ltd. (NASDAQ:FTAI) between July 23, 2024, and January 15, 2025, both dates inclusive (the "Class Period"), of the important March 18, 2025 lead plaintiff deadline.

image for news ROSEN, LEADING TRIAL ATTORNEYS, Encourages FTAI Aviation Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTAI

NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129938&wire=1 or contact Joseph E. Levi, Esq.

image for news Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT

NEW YORK, NY / ACCESS Newswire / February 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Grocery Outlet Holding Corp. (NASDAQ:GO) between November 7, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important March 31, 2025 lead plaintiff deadline. SO WHAT: If you purchased Grocery Outlet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Grocery Outlet Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GO

NEW YORK, NY / ACCESS Newswire / February 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ:AZN) between February 23, 2022 and December 17, 2024, both dates inclusive (the "Class Period"), of the February 21, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased AstraZeneca securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news AZN DEADLINE NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN

JPMorgan Chase has reportedly declined to share its private credit lending data with regulators. As the Financial Times (FT) reported Saturday (Feb. 15), this decision hinders efforts by the likes of the Federal Deposit Insurance Corp. (FDIC) to gauge the depth of connections between banks, buyout firms and the fast-growing private lending sector.

image for news JPMorgan Declines to Share Private Credit Lending Data With Regulators

For the last couple of years, the stock market has rallied on an unwaveringly positive narrative surrounding the prospects of artificial intelligence (AI). The momentum that's fueled technology stocks in particular carried into 2025 -- until about two weeks ago, when the party music suddenly stopped out of nowhere.

image for news Cathie Wood Goes Bargain Hunting. Here's 1 "Magnificent Seven" Stock She Just Bought on the DeepSeek Dip.

RADNOR, Pa. , Feb. 16, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period").

image for news APLT Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit

Is Cava a Buy, Sell, or Hold in 2025? — Positive

CAVA   The Motley Fool — February 16, 2025

The S&P 500 has risen about 20% over the past 12 months, which is a very strong performance. Cava Group's (CAVA 0.44%) stock price has rallied 160% over the same span.

image for news Is Cava a Buy, Sell, or Hold in 2025?

Is This Vanguard ETF a Millionaire Maker? — Positive

VOO   The Motley Fool — February 16, 2025

Everyone would love to make a million dollars through investing -- and there are various ways to set yourself off on the right path. One way is to invest in a broad range of quality stocks and hold on to them for the long term.

image for news Is This Vanguard ETF a Millionaire Maker?